1. Deficiency of N-linked glycosylation impairs immune function of B7-H6
    Hanqing Chen et al, 2023, Frontiers in Immunology CrossRef
  2. NK Cell Adoptive Immunotherapy of Cancer: Evaluating Recognition Strategies and Overcoming Limitations
    Carlos E. Sanchez et al, 2021, Transplantation and Cellular Therapy CrossRef
  3. Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy
    Aura Muntasell et al, 2017, Frontiers in Immunology CrossRef
  4. Bromodomain protein BRD4 is an epigenetic activator of B7-H6 expression in acute myeloid leukemia
    Aroa Baragaño Raneros et al, 2021, OncoImmunology CrossRef
  5. Immune checkpoints and cancer immunotherapies: insights into newly potential receptors and ligands
    Ali N. Kamali et al, 2023, Therapeutic Advances in Vaccines and Immunotherapy CrossRef
  6. Novel immune checkpoint targets: A promising therapy for cancer treatments
    Mohsina Patwekar et al, 2024, International Immunopharmacology CrossRef
  7. The prognostic value of B7-H6 in esophageal squamous cell carcinoma
    Huan Zhou et al, 2019, Scientific Reports CrossRef
  8. Beyond Programmed Death-Ligand 1: B7-H6 Emerges as a Potential Immunotherapy Target in SCLC
    Portia L. Thomas et al, 2021, Journal of Thoracic Oncology CrossRef
  9. Immune checkpoint molecules B7-H6 and PD-L1 co-pattern the tumor inflammatory microenvironment in human breast cancer
    Boutheina Cherif et al, 2021, Scientific Reports CrossRef
  10. Insights Into Mechanisms of Tumor and Immune System Interaction: Association With Wound Healing
    Aleksandr V. Ponomarev et al, 2019, Frontiers in Oncology CrossRef
  11. B7-H6 as a Diagnostic Biomarker for Cervical Squamous Cell Carcinoma
    Xuejing Liu et al, 2021, Genetic Testing and Molecular Biomarkers CrossRef
  12. The potential of B7-H6 as a therapeutic target in cancer immunotherapy
    Alaleh Mohammadi et al, 2022, Life Sciences CrossRef
  13. Expression of B7-H6 expression in human hepatocellular carcinoma and its clinical significance
    Lujun Chen et al, 2018, Cancer Cell International CrossRef
  14. Dual role of B7‐H6 as a novel prognostic marker in hepatocellular carcinoma
    Hao Qiu et al, 2021, APMIS CrossRef
  15. Preferential Expression of B7-H6 in Glioma Stem-Like Cells Enhances Tumor Cell Proliferation via the c-Myc/RNMT Axis
    Hanqing Chen et al, 2020, Journal of Immunology Research CrossRef
  16. Deficient Natural Killer Cell NKp30‐Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma
    Stefania Mantovani et al, 2019, Hepatology CrossRef
  17. B7H6 Serves as a Negative Prognostic Marker and an Immune Modulator in Human Pancreatic Cancer
    Zheng Zhu et al, 2022, Frontiers in Oncology CrossRef

  18. B7-H6 Promotes Cell Proliferation, Migration and Invasion of Non-Hodgkin Lymphoma via Ras/MEK/ERK Pathway Based on Quantitative Phosphoproteomics Data


    Siyuan Yang et al, 2020, OncoTargets and Therapy CrossRef
  19. Comprehensive molecular profiling of the B7 family in gastrointestinal cancer
    Qijie Zhao et al, 2018, Cell Proliferation CrossRef
  20. All‐trans retinoic acid induces leukemia resistance to NK cell cytotoxicity by down‐regulating B7‐H6 expression via c‐Myc signaling
    Guoshuai Cao et al, 2021, Cancer Communications CrossRef